HOME >> BIOLOGY >> NEWS
New guidelines show significant benefits of FUZEON for wide range of pre-treated HIV/AIDS patients

New international consensus guidelines for FUZEON (enfuvirtide) are published today in AIDS, the official journal of the International AIDS Society. These guidelines are vital because they balance the significant benefits of FUZEON with the need for self-injection and also provide a clear framework for FUZEON use.

The independent consensus panel of nine leading experts from around the world agreed that:

  • FUZEON represents an important advance in HIV therapy
  • With ongoing training and support, healthcare professionals can assist patients in successfully introducing FUZEON into their daily routines
  • FUZEON benefits pre-treated patients across all sub-groups studied, including those taking few or no other active drugs
  • Optimal outcomes are achieved when FUZEON is used in patients who have a higher CD4 count (> or equal to 100 versus < or equal to 100 cells/mm)
  • An initial investment in establishing patient training programmes yield significant returns in the maintenance of adherence, patient confidence, and in the benefit of FUZEON therapy

"FUZEON is an important treatment for the increasing number of patients with HIV drug resistance. By providing clear advice on timing of FUZEON initiation and patient support during therapy, these guidelines clarify the place of this breakthrough drug in current HIV treatment regimens and will enable more pre-treated patients to benefit," stated Dr Mike Youle, Royal Free Hospital, London.

Mr Colin Webb, Executive Director of European Coalition of Positive People (ECPP) commented, "The ECPP welcomes these international consensus guidelines for FUZEON. They are important as they encourage further dialogue between physicians and their patients, ensuring that informed decisions are made on when to consider and successfully introduce FUZEON."


'"/>

Contact: Amanda Boswell
amanda.boswell@ketchum.com
44-207-611-3571
Ketchum
16-May-2004


Page: 1

Related biology news :

1. International critical care doctors release first-ever guidelines for sepsis
2. Revised guidelines published for testing for hereditary type of colorectal cancer
3. New ACOG guidelines on progesterone to prevent preterm birth praised by March of Dimes
4. Ethical guidelines needed before nutrigenomic groceries come to market
5. New guidelines can help health officials better predict and control dengue epidemics
6. Researchers develop guidelines to establish identity of genes responsible for complex diseases
7. Aborigine study suggests body mass index guidelines should be lower to block diabetes
8. New nutrition guidelines for diabetics promote emphasis on high-monounsaturated fat diet
9. Conservation International and Starbucks announce new coffee sourcing guidelines
10. Report on dietary supplements containing ephedra makes urgent call for research to develop dose guidelines, safety warnings
11. Current HIV treatment guidelines may result in more men than women being eligible for treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2019)... ... May 01, 2019 , ... uBiome, the ... John Rakow, the Company’s General Counsel, as Interim Chief Executive Officer of uBiome, ... currently on administrative leave. There will also be an independent investigation into uBiome’s ...
(Date:4/25/2019)... ... April 23, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is ... in Egg Harbor Township, New Jersey. The new facility was custom designed to ...
(Date:4/25/2019)... ... April 24, 2019 , ... NDA Partners Chairman Carl Peck, MD , ... experience in the development of drug and genomic diagnostic products for therapeutic indications in ... NDA Partners, Dr. Maddala served as Vice President of Biometrics at GRAIL, Inc., where ...
Breaking Biology News(10 mins):
(Date:5/2/2019)... S.D. (PRWEB) , ... April 30, 2019 , ... The ... from industrial scale macro breweries to local craft breweries, and even home brewing clubs ... very complex chemical and biological processes, that when mastered can produce a superb product. ...
(Date:5/2/2019)... (PRWEB) , ... May 02, 2019 , ... ... genetics testing company, will present results documenting discrepancies between U.S. insurer policies for ... for patients at risk for hereditary breast and ovarian cancer (HBOC). ...
(Date:4/25/2019)... , ... April 23, 2019 , ... Frank is an albino, deaf Great Dane. His ... want him due to his health issues. Despite his hearing impairment, he was always an ... the two would play all day, every day. As the two grew, playtime became rougher ...
(Date:4/18/2019)... (PRWEB) , ... April 18, 2019 , ... ... fuels, a research team that includes a chemical engineer at Worcester Polytechnic Institute ... microorganism that may make it possible to manufacture isobutanol and other biofuels more ...
Breaking Biology Technology:
Cached News: